Search

Search Results
Results 121 - 130 of 144 for Acute inflammation
  • Invanz
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Invanz intended for persons living in Australia.
  • Incruse Ellipta
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Incruse Ellipta intended for persons living in Australia.
  • Vttack
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Vttack intended for persons living in Australia.
  • Olamlo HCT
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Olamlo HCT (Olmesartan medoxomil, amlodipine and hydrochlorothiazide) intended for persons living in Australia.
  • Midazolam Viatris
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Midazolam Viatris intended for persons living in Australia.
  • Abisart HCTZ
    Drug - 27 Mar 2023
    Consumer Medicine Information (CMI) about Abisart HCTZ intended for persons living in Australia.
  • Imatinib-Teva
    Drug - 9 Jan 2023
    Consumer Medicine Information (CMI) about Imatinib-Teva intended for persons living in Australia.
  • Adenuric tablets
    Drug - 7 Nov 2022
    Consumer Medicine Information (CMI) about Adenuric tablets intended for persons living in Australia.
  • Reaptan
    Drug - 2 Aug 2022
    Consumer Medicine Information (CMI) about Reaptan (Perindopril/amlodipine [pronounced per-in-do-pril/ am-load-i-peen]) intended for persons living in Australia.
  • Natrilix SR
    Drug - 26 Jul 2022
    Consumer Medicine Information (CMI) about Natrilix SR (Sustained Release tablets containing indapamide) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback